Ati cautat: boli renale
Romania trebuie sa revizuiasca abordarea terapeutica a diabetului
Protocol terapeutic: V004N – DCI AMINOACIZI, INCLUSIV COMBINAŢII CU POLIPEPTIDE (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: V002D – DCI DEFERASIROXUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: M003M – OSTEOPOROZA – ACIDUM ALENDRONICUM**; ACIDUM RISEDRONICUM**; ACIDUM ZOLENDRONICUM**; COMBINAŢII (ACIDUM ALENDRONICUM + COLECALCIFEROLUM)**; DENOSUMABUM(Prolia)**; TERIPARATIDUM**(original si biosimilar) (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L050C – DCI INTERFERONUM ALFA 2A (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L047C – DCI PEMETREXEDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L032C – DCI PEGFILGRASTIMUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L002G – DCI TRATAMENT IMUNOMODULATOR – SCLEROZĂ MULTIPLĂ (actualizat APRILIE 2022 conform ordin MS/CNAS NR 1206/233/2022)
Protocol terapeutic: H004E – DCI CETRORELIXUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: C008N – DCI IRBESARTANUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
